http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2003520237-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12 |
| filingDate | 2001-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2003-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2003520237-A |
| titleOfInvention | Combinations containing mirtrazapine and gepirone for the treatment of depression and related diseases |
| abstract | (57) [Summary]nThe present invention relates to miltrazapine, or a pharmaceutically acceptable salt or solvate thereof, and gepirone, or a pharmaceutically acceptable salt or solvate thereof, optionally together with one or more pharmaceutically acceptable carriers. And a combination drug in which the gepirone and mirtrazapine are present in an amount such that the effect of the composition is higher than the additive effect of the same amount of each drug. This combination can be used in the treatment of depression and related diseases, and thus the present invention also provides a new method of treating depression and related diseases. |
| priorityDate | 2000-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 26.